PASSAGE BIO INC (PASG)
US7027121000 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 32.29M | 21.71M | 34.60M | 129.00M | 135.00M | |||
| Marketable Securities | 52.53M | 92.58M | 155.00M | 186.80M | 169.80M | |||
| Other Current Assets | 2.39M | 3.67M | 7.40M | 9.30M | 12.40M | |||
| Total Current Assets | 87.22M | 117.96M | 197.00M | 325.10M | 317.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 24.07M | 32.15M | 42.20M | 23.80M | 2.80M | |||
| Other Non-Current Assets | 463.00K | 433.00K | 4.30M | 6.20M | 8.00M | |||
| Total Non-Current Assets | 24.54M | 32.59M | 46.50M | 30.00M | 10.80M | |||
| TOTAL ASSETS | 111.75M | 150.54M | 243.50M | 355.10M | 328.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 10.46M | 13.04M | 14.20M | 19.40M | 15.40M | |||
| Accounts Payable | 1.49M | 1.30M | 4.10M | 9.40M | 5.30M | |||
| Other Current Liabilities | 5.00M | 2.00M | 100.00K | 700.00K | 500.00K | |||
| Total Current Liabilities | 16.95M | 16.34M | 18.40M | 29.50M | 21.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 22.09M | 22.92M | 23.80M | 6.90M | 2.10M | |||
| Total Non-Current Liabilities | 22.09M | 22.92M | 23.80M | 6.90M | 2.10M | |||
| TOTAL LIABILITIES | 39.04M | 39.26M | 42.20M | 36.40M | 23.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -646.51M | -594.47M | -492.40M | -356.30M | -170.90M | |||
| Additional Paid In Capital | 719.19M | 705.79M | 694.70M | 675.30M | 475.60M | |||
| Common Shares | 6.00K | 5.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 32.00K | -43.00K | -1.00M | -400.00K | 0.00 | |||
| Shares Outstanding | 61.77M | 54.94M | 54.60M | 54.20M | 45.60M | |||
| Tangible Book Value per Share | 1.18 | 2.03 | 3.69 | 5.88 | 6.68 | |||
| Total Shareholders' Equity | 72.72M | 111.28M | 201.40M | 318.70M | 304.70M | |||
| TOTAL LIABILITIES AND EQUITY | 111.75M | 150.54M | 243.50M | 355.10M | 328.00M | |||
| Statistics | ||||||||
| Current Ratio | 5.15 | 7.22 | 10.71 | 11.02 | 14.96 | |||
| Return On Assets (ROA) | -61.56% | -67.80% | -55.91% | -52.21% | -34.22% | |||
| Return On Equity (ROE) | -94.61% | -91.71% | -67.59% | -58.17% | -36.83% | |||
All data in USD , ROIC based on taxRate of 0.21